Filing Flows › BioNexus Gene Lab (BGLC) › Q1 2026 › vs Q1 2025
BioNexus Gene Lab (BGLC) Q1 2026 vs Q1 2025 (year over year)
BioNexus Gene Lab's revenue fell $2.1M (-99%) from $2.1M in Q1 2025 to $23K in Q1 2026.
BioNexus Gene Lab, Q1 2026: revenue $23K (-99% year over year), net loss $544K, operating cash flow −$148K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $23K | $2.1M | −$2.1M | -99% |
| Net loss | $544K | $623K | −$80K | -13% |
| Costs & expenses | $566K | $2.8M | −$2.2M | -79% |
| Operating costs | $563K | $2.8M | −$2.2M | -80% |
| Interest & other, net | $3K | $5K | −$2K | -37% |
| Research & development | $14K | $12K | $2K | +19% |
| Sales & marketing | $53K | $541K | −$488K | -90% |
| General & admin | $328K | $392K | −$64K | -16% |
| Other operating costs | $145K | $17K | $128K | +742% |
| Operating cash sources | $544K | $623K | −$80K | -13% |
| Depreciation | $28K | $27K | $2K | +6% |
| Working capital & other | $368K | −$227K | $595K | — |
| Cash used in operations | $148K | $824K | −$676K | -82% |
| Net loss absorbed | $544K | $623K | −$80K | -13% |
Questions
How much did BioNexus Gene Lab's revenue grow year over year in Q1 2026?
BioNexus Gene Lab's revenue fell $2.1M (-99%) from $2.1M in Q1 2025 to $23K in Q1 2026.